We are live on
!
Find out more
Westfield Capital Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
49.45%
This Fund
S&P 500
This Quarter
Est. Return
+13.66%
1 Year Est. Return
+49.45%
3 Year Est. Return
+148.08%
5 Year Est. Return
+180.9%
10 Year Est. Return
+972.69%
AUM
$14B
AUM Growth
+$1.55B
(+12%)
Cap. Flow
+$55.8M
Cap. Flow
% of AUM
0.4%
Top 10 Holdings %
Top 10 Hldgs %
20.04%
Holding
266
New
32
Increased
101
Reduced
90
Closed
35
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TransDigm Group
TDG
|
+$114M |
| 2 |
Novartis
NVS
|
+$98.3M |
| 3 |
Carter's
CRI
|
+$80.1M |
| 4 |
Brixmor Property Group
BRX
|
+$77.5M |
| 5 |
Citigroup
C
|
+$75.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MDCO
Medicines Co
MDCO
|
+$340M |
| 2 |
Adobe
ADBE
|
+$106M |
| 3 |
Marriott International
MAR
|
+$99.8M |
| 4 |
Cisco
CSCO
|
+$81.3M |
| 5 |
Progressive
PGR
|
+$62.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.58% |
| 2 | Healthcare | 17.58% |
| 3 | Industrials | 13.74% |
| 4 | Financials | 11.64% |
| 5 | Consumer Discretionary | 10.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
MKS Inc
MKSI
$20.4B
| $23.3M | 0.17% |
+211,735
| New | +$22.2M |
|
152
lululemon athletica
LULU
$14.2B
| $23.2M | 0.17% |
100,290
-213,669
| -68% | -$45.5M |
|
153
Integra LifeSciences
IART
$1.36B
| $22.8M | 0.16% |
391,899
-3,478
| -0.9% | -$207K |
|
154
Viavi Solutions
VIAV
$9.97B
| $22.6M | 0.16% |
1,508,871
-37,016
| -2% | -$554K |
|
|
CCMP
155
DELISTED
CMC Materials, Inc. Common Stock
CCMP
| $22.5M | 0.16% |
155,997
-42,107
| -21% | -$5.98M |
|
156
Bright Horizons
BFAM
$3.89B
| $22.5M | 0.16% |
149,664
-1,539
| -1% | -$231K |
|
157
Hamilton Lane
HLNE
$5.46B
| $22.1M | 0.16% |
370,743
+53,696
| +17% | +$3.1M |
|
158
Old Dominion Freight Line
ODFL
$44.1B
| $21.8M | 0.16% |
345,120
-58,755
| -15% | -$3.61M |
|
159
Advanced Energy
AEIS
$13.1B
| $20.9M | 0.15% |
+293,223
| New | +$18.2M |
|
160
Repligen
RGEN
$8.99B
| $20.8M | 0.15% |
+224,884
| New | +$18.9M |
|
161
Rogers Corp
ROG
$2.38B
| $20.7M | 0.15% |
166,349
+11,952
| +8% | +$1.62M |
|
162
Ryder
R
$10.1B
| $19.9M | 0.14% |
366,257
-6,029
| -2% | -$314K |
|
|
EPAY
163
DELISTED
Bottomline Technologies Inc
EPAY
| $19.5M | 0.14% |
+362,940
| New | +$16.5M |
|
164
ACI Worldwide
ACIW
$5.64B
| $19.4M | 0.14% |
+511,192
| New | +$17.4M |
|
165
First Hawaiian
FHB
$3.37B
| $19.3M | 0.14% |
668,206
+151,446
| +29% | +$4.26M |
|
166
NMI Holdings
NMIH
$3.3B
| $18.7M | 0.13% |
+562,139
| New | +$17.6M |
|
167
SiTime
SITM
$19.5B
| $18.6M | 0.13% |
+728,497
| New | +$14.4M |
|
168
Palomar
PLMR
$3.58B
| $18.5M | 0.13% |
367,373
-20,090
| -5% | -$941K |
|
169
Rocket Pharmaceuticals
RCKT
$388M
| $18.2M | 0.13% |
797,596
+11,482
| +1% | +$192K |
|
170
Insperity
NSP
$1.94B
| $18.1M | 0.13% |
+210,376
| New | +$18.3M |
|
171
Paylocity
PCTY
$8.28B
| $18M | 0.13% |
149,081
-558
| -0.4% | -$61.1K |
|
|
SAGE
172
DELISTED
Sage Therapeutics
SAGE
| $17.8M | 0.13% |
247,209
+100,248
| +68% | +$12.3M |
|
|
SRC
173
DELISTED
SPIRIT REALTY CAPITAL, INC.
SRC
| $17.7M | 0.13% |
359,638
-976,808
| -73% | -$48.6M |
|
|
WWE
174
DELISTED
World Wrestling Entertainment
WWE
| $14.9M | 0.11% |
230,065
+101,000
| +78% | +$6.39M |
|
175
FirstCash
FCFS
$8.98B
| $14.5M | 0.1% |
179,236
-106,686
| -37% | -$8.97M |
|
Similar funds
OAG
JG
CHP
SC
Westfield Capital Management's Q4 2019 Portfolio in Review
As of Q4 2019, Westfield Capital Management held 266 positions worth $14B, up 12% from $12.5B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Westfield Capital Management's Q4 2019 filing shows 32 new, 101 increased, 90 reduced and 35 closed positions. Its largest new stake was Novartis: 1,095,518 shares worth $104M. The largest sale was Medicines Co, an estimated $340M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 28% a quarter earlier, followed by Healthcare and Industrials.
- Westfield Capital Management's largest Q4 2019 buy was Novartis: 1,095,518 shares worth $104M.
- Westfield Capital Management added most to TransDigm Group in Q4 2019, an estimated $114M increase.
- Westfield Capital Management's biggest Q4 2019 reduction was Medicines Co, cutting an estimated $340M.
- Westfield Capital Management fully exited Adobe in Q4 2019, selling an estimated $106M.
- Westfield Capital Management's ten largest holdings make up 20% of its $14B portfolio in Q4 2019.
- Westfield Capital Management opened 32 new positions and closed 35 in Q4 2019.
- Westfield Capital Management's portfolio value rose 12% quarter-over-quarter to $14B.
Based on Westfield Capital Management's 13F filing for Q4 2019, filed 13 Feb 2020.